Recombinant human epidermal growth factor treatment of radiation-induced severe oral mucositis in patients with head and neck malignancies

Mucositis of the oral cavity and pharynx is a major dose-limiting factor in the application of radiotherapy (RT) to patients with head and neck cancer. Therefore, we evaluated the wound healing effect of human recombinant epidermal growth factor (rhEGF) in head and neck cancer and lymphoma patients...

Descripción completa

Detalles Bibliográficos
Autores principales: HONG, JP, LEE, S-W, SONG, SY, AHN, SD, SHIN, SS, CHOI, EK, KIM, JH
Formato: Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2009
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2776929/
https://www.ncbi.nlm.nih.gov/pubmed/19456848
http://dx.doi.org/10.1111/j.1365-2354.2008.00971.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2776929/
https://www.ncbi.nlm.nih.gov/pubmed/19456848
http://dx.doi.org/10.1111/j.1365-2354.2008.00971.x

Ejemplares similares